There is an increasing realisation across several stakeholders including industry and regulatory agencies that post regulatory approval studies may be more effectively performed through registry-based studies that collect real world data through a joint collaborative approach between all stakeholders. Such an approach can also serve the needs of the wider community in assessing clinical outcomes that require long-term follow-up, a facet that is particularly important in paediatric therapy. GloBE-Reg is developing a platform that can support post-regulatory approval studies for several novel therapies. The steering committee of GloBE-Reg consists of representatives from a wide range of paediatric endocrine organisations and members of industry.
The Project Team
The project team of GloBE-Reg is based at the Office for Rare Conditions at the University of Glasgow, Glasgow, Scotland, United Kingdom. The team has played a leading role in several successful international registry projects including I-DSD, I-CAH, I-TS, EuRRECa and EuRR-Bone.
We are proud to be working with the following partners and grateful to industry for their support.
Latest GloBE-Reg News:
The ESPE Education and Training Committee is delighted to announce the fifth webinar in their ESPE Connect webinar series. About this event…Keep reading
Book your place on the Live Webinar, “The Role of rhGH Therapy in Turner Syndrome (TS): Growth and Quality of Life”
Taking place on Thursday, 16 June 2022 from 13.00 to 14.00 CEST, and organised by Scientific Seminars Foundation. In the Final Program,…Keep reading
Get in Touch
We are very excited about this new project and are in the process of building this website. If you would like to find out more right now, feel free to contact email@example.com.
You can also follow us on Twitter: https://twitter.com/GloBE_Reg.